Beone Medicines
Clinical trials sponsored by Beone Medicines, explained in plain language.
-
New cancer drug shows promise in early trial for Hard-to-Treat tumors
Disease control TerminatedThis study tested a new drug called BG-89894 in 29 people with advanced solid tumors that have a specific genetic change (MTAP deletion). The main goals were to check safety, find the best dose, and see if the drug can shrink tumors. The study was stopped early, but the informati…
Phase: PHASE1 • Sponsor: BeOne Medicines • Aim: Disease control
Last updated May 15, 2026 11:56 UTC
-
New cancer drug combo tested in early trial
Disease control TerminatedThis early-stage study tested a new experimental drug called BGB-R046, given alone or with another drug (tislelizumab), in 42 people with advanced or spreading solid tumors that had not responded to standard treatments. The main goals were to check safety, find the best dose, and…
Phase: PHASE1 • Sponsor: BeOne Medicines • Aim: Disease control
Last updated May 12, 2026 13:39 UTC